Wells Fargo’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-21,550
| Closed | -$11K | – | 6265 |
|
2016
Q3 | $11K | Buy |
21,550
+17,000
| +374% | +$8.68K | ﹤0.01% | 5434 |
|
2016
Q2 | $2K | Sell |
4,550
-14,945
| -77% | -$6.57K | ﹤0.01% | 5666 |
|
2016
Q1 | $28K | Buy |
19,495
+3,730
| +24% | +$5.36K | ﹤0.01% | 5206 |
|
2015
Q4 | $50K | Sell |
15,765
-56
| -0.4% | -$178 | ﹤0.01% | 5074 |
|
2015
Q3 | $99K | Sell |
15,821
-2,126
| -12% | -$13.3K | ﹤0.01% | 4714 |
|
2015
Q2 | $179K | Buy |
17,947
+11,185
| +165% | +$112K | ﹤0.01% | 4530 |
|
2015
Q1 | $49K | Sell |
6,762
-686
| -9% | -$4.97K | ﹤0.01% | 4833 |
|
2014
Q4 | $40K | Buy |
7,448
+4,014
| +117% | +$21.6K | ﹤0.01% | 4911 |
|
2014
Q3 | $17K | Sell |
3,434
-13,644
| -80% | -$67.5K | ﹤0.01% | 5226 |
|
2014
Q2 | $114K | Sell |
17,078
-9,641
| -36% | -$64.4K | ﹤0.01% | 4523 |
|
2014
Q1 | $194K | Buy |
26,719
+25,219
| +1,681% | +$183K | ﹤0.01% | 4274 |
|
2013
Q4 | $6K | Buy |
+1,500
| New | +$6K | ﹤0.01% | 5193 |
|